The benefit of human chorionic gonadotropin supplementation throughout the secretory phase of frozen-thawed embryo transfer cycles
To access this article, please choose from the options below
A.B.-M. has nothing to disclose. M.A.-D. has nothing to disclose. A.R. has nothing to disclose. E.E. has nothing to disclose. N.L. has nothing to disclose. A.S. has nothing to disclose.
PII: S0015-0282(09)00370-7
doi:10.1016/j.fertnstert.2009.02.027
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

